159 related articles for article (PubMed ID: 37983669)
1. Analytic and Clinical Validity of Myositis-Specific Antibodies by Line-Blot Immunoassay Is Essential.
Tseng CW; Satoh M; Hasegawa T; Tanaka S; Chen YM
J Clin Rheumatol; 2024 Jan; 30(1):e23-e28. PubMed ID: 37983669
[TBL] [Abstract][Full Text] [Related]
2. An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations.
Fredi M; Cavazzana I; Ceribelli A; Cavagna L; Barsotti S; Bartoloni E; Benucci M; De Stefano L; Doria A; Emmi G; Fabris M; Fornaro M; Furini F; Giudizi MG; Govoni M; Ghirardello A; Iaccarino L; Iannone F; Infantino M; Isailovic N; Lazzaroni MG; Manfredi M; Mathieu A; Marasco E; Migliorini P; Montecucco C; Palterer B; Parronchi P; Piga M; Pratesi F; Riccieri V; Selmi C; Tampoia M; Tripoli A; Zanframundo G; Radice A; Gerli R; Franceschini F;
Clin Rev Allergy Immunol; 2022 Oct; 63(2):240-250. PubMed ID: 35092577
[TBL] [Abstract][Full Text] [Related]
3. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.
Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M
J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464
[TBL] [Abstract][Full Text] [Related]
5. Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.
Cavazzana I; Fredi M; Ceribelli A; Mordenti C; Ferrari F; Carabellese N; Tincani A; Satoh M; Franceschini F
J Immunol Methods; 2016 Jun; 433():1-5. PubMed ID: 26906088
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.
Mahler M; Miller FW; Fritzler MJ
Autoimmun Rev; 2014; 13(4-5):367-71. PubMed ID: 24424190
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.
Damoiseaux J; Vulsteke JB; Tseng CW; Platteel ACM; Piette Y; Shovman O; Bonroy C; Hamann D; De Langhe E; Musset L; Chen YH; Shoenfeld Y; Allenbach Y; Bossuyt X
Autoimmun Rev; 2019 Mar; 18(3):293-305. PubMed ID: 30639643
[TBL] [Abstract][Full Text] [Related]
8. [Myositis-specific autoantibodies].
Gran JT; Molberg Ø; Dobloug GC; Andersson H; Taraldsrud E; Scheie D
Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1631-4. PubMed ID: 19721478
[TBL] [Abstract][Full Text] [Related]
9. A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.
Tampoia M; Notarnicola A; Abbracciavento L; Fontana A; Giannini M; Louis Humbel R; Iannone F
J Clin Lab Anal; 2016 Nov; 30(6):859-866. PubMed ID: 27074881
[TBL] [Abstract][Full Text] [Related]
10. Immune cell profiles of idiopathic inflammatory myopathy patients expressed anti-aminoacyl tRNA synthetase or anti-melanoma differentiation-associated gene 5 autoantibodies.
Lan JL; Chang SH; Tsay GJ; Chen DY; Chao YH; Li JP
BMC Immunol; 2023 Sep; 24(1):33. PubMed ID: 37752437
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
[TBL] [Abstract][Full Text] [Related]
12. Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.
Piette Y; De Sloovere M; Vandendriessche S; Dehoorne J; De Bleecker JL; Van Praet L; Vander Mijnsbrugge AS; De Schepper S; Jacques P; De Keyser F; Smith V; Bonroy C
Clin Exp Rheumatol; 2020; 38(2):212-219. PubMed ID: 31287411
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
14. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
[TBL] [Abstract][Full Text] [Related]
15. Murine models of idiopathic inflammatory myopathy.
Konishi R; Ichimura Y; Okiyama N
Immunol Med; 2023 Mar; 46(1):9-14. PubMed ID: 36282924
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes.
Liu D; Zhao L; Jiang Y; Li L; Guo M; Mu Y; Zhu H
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2456-2472. PubMed ID: 35860906
[TBL] [Abstract][Full Text] [Related]
17. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
[TBL] [Abstract][Full Text] [Related]
18. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.
Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835823
[TBL] [Abstract][Full Text] [Related]
19. Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein properties.
Ichimura Y; Konishi R; Shobo M; Inoue S; Okune M; Maeda A; Tanaka R; Kubota N; Matsumoto I; Ishii A; Tamaoka A; Shimbo A; Mori M; Morio T; Kishi T; Miyamae T; Tanboon J; Inoue M; Nishino I; Fujimoto M; Nomura T; Okiyama N
J Dermatol; 2022 Apr; 49(4):441-447. PubMed ID: 34967032
[TBL] [Abstract][Full Text] [Related]
20. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity.
So H; So J; Lam TT; Wong VT; Ho R; Li WL; Mok CC; Lau CS; Tam LS
Arthritis Rheumatol; 2022 Sep; 74(9):1588-1592. PubMed ID: 35467787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
